Roche announced today the launch of a new R&D Institute in France under the lead of the companyâ??s Pharma Research and Early Development (pRED) unit. The pRED French R&D Institute will be fully dedicated to collaborative translational research and medicine, with the objective to build in-depth strategic partnerships with leading French academic centers in areas of mutual interest. The Institute will serve as the single entry-point for academic collaborations in France across multiple disease areas and scientific disciplines: oncology, neurosciences, metabolism, inflammation, virology, translational research and toxicology.
